Prelude Therapeutics
PRLD
#9185
Rank
A$0.11 B
Marketcap
$2.08
Share price
46.40%
Change (1 day)
-66.44%
Change (1 year)

Prelude Therapeutics (PRLD) Fails to deliver data

Key failure to deliver metrics for Prelude Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prelude Therapeutics (PRLD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prelude Therapeutics (PRLD) - since 2020

Volume in USD (price x number of shares), data since 2020

Prelude Therapeutics (PRLD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.32 M-95.2%
2023A$6.79 M147.35%
2022A$2.74 M-92.53%
2021A$36.76 M233.95%
2020A$11 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1 MA$6 M๐Ÿ‡บ๐Ÿ‡ธ USA